Search results
- 1.0584812 - BTÚ 2025 RIV US eng J - Journal Article
Sychra, T. - Spalenkova, A. - Balatka, S. - Václavíková, R. - Šeborová, K. - Ehrlichová, M. - Truksa, Jaroslav - Sandoval-Acuna, Cristian - Němcová, V. - Szabo, A. - Kočí, K. - Tesarova, T. - Chen, L. - Ojima, I. - Oliverius, M. - Souček, P.
Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma.
iScience. Roč. 27, č. 2 (2024), č. článku 109044. E-ISSN 2589-0042
R&D Projects: GA ČR(CZ) GA21-14082S
Institutional support: RVO:86652036
Keywords : biological evaluation * cancer * microenvironment * cytotoxicity * transport * design
OECD category: Biochemistry and molecular biology
Impact factor: 5.8, year: 2022
Method of publishing: Limited access
https://www.sciencedirect.com/science/article/pii/S2589004224002657?via%3Dihub
Permanent Link: https://hdl.handle.net/11104/0352753 - 2.0565763 - BTÚ 2023 RIV CH eng J - Journal Article
Šeborová, K. - Koucká, K. - Spalenkova, A. - Holý, P. - Ehrlichová, M. - Sychra, T. - Chen, L. - Bendale, H. - Ojima, I. - Sandoval-Acuna, Cristian - Truksa, Jaroslav - Souček, P. - Václavíková, R.
Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model.
Frontiers in Pharmacology. Roč. 13, NOV 9 2022 (2022), č. článku 971905. ISSN 1663-9812. E-ISSN 1663-9812
R&D Projects: GA ČR(CZ) GA21-14082S
Institutional support: RVO:86652036
Keywords : ovarian carcinoma * resistance * paclitaxel * SB-T taxanes * efficacy * in vitro * in vivo
OECD category: Pharmacology and pharmacy
Impact factor: 5.6, year: 2022
Method of publishing: Open access
https://www.frontiersin.org/articles/10.3389/fphar.2022.971905/full
Permanent Link: https://hdl.handle.net/11104/0337429